IP Library › Granted Patent US 12,259,351
Granted Patent B2
US 12,259,351 · App. 16/402,013 · Granted Mar 25, 2025

Automatic analyte sensor calibration and error detection

Inventors: Peter C Simpson (Cardiff, CA); Ted T Lee (San Diego, CA); Jonathan M Hughes (Encinitas, CA); Stephen J. Vanslyke (Carlsbad, CA); Matthew D. Wightlin (San Diego, CA)
Assignee: Dexcom, Inc.
G01N27/3274A61B5/14532A61B5/1495A61B2560/0223
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,259,351
App. No.
16/402,013
Filed
May 2, 2019
Granted
Mar 25, 2025
Kind
B2
Examiner
SUN, XIUQIN
Art Unit
2857
USPC
702/104
Abstract

Systems and methods are provided that address the need to frequently calibrate analyte sensors, according to implementation. In more detail, systems and methods provide a preconnected analyte sensor system that physically combines an analyte sensor to measurement electronics during the manufacturing phase of the sensor and in some cases in subsequent life phases of the sensor, so as to allow an improved recognition of sensor environment over time to improve subsequent calibration of the sensor.

Claims (33)

1. A method for self-calibration of an analyte sensor system that includes a glucose sensor operatively coupled to sensor electronics, the method comprising:

applying a bias voltage with the sensor electronics to generate sensor data, the analyte sensor system having an initial characteristic metric determined at a first time;

using the sensor electronics at a second time subsequent to the first time to determine a change to the initial characteristic metric of the analyte sensor system based at least in part on a humidity associated with the glucose sensor while the glucose sensor is within a sterile package;

storing a relationship between impedance and humidity in a memory associated with the sensor electronics;

monitoring the humidity associated with the glucose sensor while the glucose sensor is within the sterile package, wherein the humidity is monitored between the first time and second time, the monitoring comprising:

applying a stimulus signal to at least one of a first electrode or a second electrode of the glucose sensor while the glucose sensor is within the sterile package;

measuring a signal response to the stimulus signal applied while the glucose sensor is within the sterile package;

calculating the impedance based on the signal response to the stimulus signal applied while the glucose sensor is within the sterile package;

determining a value for the humidity within the sterile package based on the calculated impedance and the relationship between impedance and humidity stored in the memory; and

determining, based at least on the calculated impedance, a duration of exposure of the glucose sensor to the value for the humidity while the glucose sensor is within the sterile package;

using the sensor electronics to automatically calibrate, without user intervention, the analyte sensor system based at least in part on the value for the humidity and the duration of exposure of the glucose sensor to the value for the humidity while the glucose sensor is within the sterile package, the automatically calibrating comprising determining an updated calibration factor; and

automatically applying the updated calibration factor, without user intervention, to a signal generated by the first electrode and the second electrode to determine a glucose concentration during use of the glucose sensor, wherein the glucose sensor is used after removal of the glucose sensor from the sterile package and after at least the stimulus signal is applied to at least one of the first electrode or the second electrode of the glucose sensor while the glucose sensor is within the sterile package.

2. The method of claim 1 , wherein the first time is subsequent to sensor fabrication and the second time is prior to sensor use in vivo or subsequent to initiation of sensor use in vivo.

3. The method of claim 1 wherein the initial characteristic metric is determined by initially calibrating the glucose sensor while the glucose sensor is operatively coupled to a sensor interface that is configured to provide an electrical communication interface between the glucose sensor and each of a manufacturing station and the sensor electronics.

4. The method of claim 3 wherein the initial characteristic metric is further determined by measuring an in vitro sensitivity characteristics of the glucose sensor.

5. The method of claim 1 , wherein the initial characteristic metric is determined by initially calibrating the glucose sensor while the glucose sensor is operatively coupled to one or more components of the sensor electronics.

6. The method of claim 5 , wherein the one or more components includes a potentiostat.

7. The method of claim 5 , wherein the glucose sensor is continuously operatively coupled to the one or more components of the sensor electronics between the first time and the second time without interruption.

8. The method of claim 7 , wherein the first time is during a first portion of a manufacturing life phase of the glucose sensor and the second time is during a second portion of the manufacturing life phase that is subsequent to packaging the glucose sensor and the one or more components of the sensor electronics in the sterile package.

9. The method of claim 7 , wherein the first time is during a manufacturing life phase of the glucose sensor and the second time is during sensor use in vivo.

10. The method of claim 1 , wherein monitoring the humidity includes measuring the humidity using a humidity sensor included in the sterile package, the humidity sensor being operatively couplable to the sensor electronics.

11. The method of claim 1 , wherein determining the change to the initial characteristic metric includes determining the change through use of a mathematical function.

12. The method of claim 1 , further comprising selecting a user to receive the analyte sensor system based at least in part on one or more glucose sensor characteristics.

13. The method of claim 12 , wherein the one or more glucose sensor characteristics includes an updated characteristic metric that is derived from the determined change to the initial characteristic metric.

14. The method of claim 1 , wherein monitoring the humidity of the glucose sensor while in the sterile package includes determining if the humidity exceeds or falls below one or more threshold values.

15. The method of claim 1 , wherein the initial characteristic metric is reflective of an initial sensor sensitivity or baseline value, or is reflective of an initial sensor sensitivity profile.

16. The method of claim 1 , further comprising deriving an initial calibration factor from the initial characteristic metric.

17. The method of claim 1 , wherein the change to the initial characteristic metric is indicative of sensor failure.

18. The method of claim 1 , wherein the determining the change to the initial characteristic metric of the analyte sensor system is based at least in part on one or more manufacturing parameters.

19. The method of claim 18 , wherein the one or more manufacturing parameters are obtained from an identifier of the glucose sensor, and wherein the identifier is affixed to the glucose sensor, or is obtained by wirelessly interrogating the glucose sensor, or is associated with a manufacturing lot from which the glucose sensor was obtained.

20. The method of claim 18 , wherein the one or more manufacturing parameters are measured prior to the second time and prior to the first time.

21. The method of claim 1 , wherein the sterile package is not worn by a user.

22. The method of claim 1 , wherein the glucose sensor is only located in the sterile package during shipping and storage of the glucose sensor.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2020
From: GARCIA, ARTURO; BHAVARAJU, NARESH C.; CLARK, BECKY L.; CRABTREE, VINCENT P.; DRING, CHRIS W.; HALAC, JASON; HUGHES, JONATHAN; JACKSON, JEFF; JEPSON, LAUREN HRUBY; LEE, DAVID I-CHUN; LEE, TED TANG; MA, RUI; MCDANIEL, ZEBEDIAH L.; MITCHELL, JASON; PAL, ANDREW ATTILA; RONG, DAITING; SHETH, DISHA B.; SIMPSON, PETER C.; VANSLYKE, STEPHEN J.; WIGHTLIN, MATTHEW D.; DAVIS, ANNA LEIGH; HAMPAPURAM, HARI; MANDAPAKA, ADITYA SAGAR; TEETER, ALEXANDER LEROY; WANG, LIAN
To: DEXCOM, INC.
Reel/Frame 051799/0403 →
Continuity (2)
Provisional Application 62666606 · May 3, 2018
Related Publication 20190339221A1 · Nov 7, 2019
References Cited (44)
US 7996158B2 · Hayter et al. · 2011 [cited by applicant]
US 10638979B2 · Gupta et al. · 2020 [cited by applicant]
US 20020070868A1 · Jeutter · 2002 [cited by examiner]
US 20040267103A1 · Li et al. · 2004 [cited by applicant]
US 20060076236A1 · Shah · 2006 [cited by examiner]
US 20080066305A1 · Wang et al. · 2008 [cited by applicant]
US 20080275365A1 · Guthrie et al. · 2008 [cited by applicant]
US 20090247856A1 · Boock et al. · 2009 [cited by applicant]
US 20100081909A1 · Budiman et al. · 2010 [cited by applicant]
US 20100217557A1 · Kamath et al. · 2010 [cited by applicant]
US 20100274515A1 · Hoss et al. · 2010 [cited by applicant]
US 20110027127A1 · Simpson et al. · 2011 [cited by applicant]
US 20110213225A1 · Bernstein et al. · 2011 [cited by applicant]
US 20110320130A1 · Valdes et al. · 2011 [cited by applicant]
US 20120323098A1 · Moein et al. · 2012 [cited by applicant]
US 20120328473A1 · Thomas · 2012 [cited by examiner]
US 20130002278A1 · Martin · 2013 [cited by examiner]
US 20130267809A1 · Brister et al. · 2013 [cited by applicant]
US 20130325352A1 · Greene et al. · 2013 [cited by applicant]
US 20140114156A1 · Böhm et al. · 2014 [cited by applicant]
US 20160015303A1 · Bernstein et al. · 2016 [cited by applicant]
US 20160081597A1 · Bhavaraju et al. · 2016 [cited by applicant]
US 20160298988A1 · Hahn et al. · 2016 [cited by applicant]
US 20170071511A1 · Garcia et al. · 2017 [cited by applicant]
US 20170071512A1 · Garcia et al. · 2017 [cited by applicant]
US 20180008174A1 · Bohm · 2018 [cited by examiner]
US 20190117133A1 · Halac et al. · 2019 [cited by applicant]
US 20190117138A1 · Budiman et al. · 2019 [cited by applicant]
US 20190274598A1 · Scott et al. · 2019 [cited by applicant]
US 20190339222A1 · Bhavaraju et al. · 2019 [cited by applicant]
US 20190339223A1 · Bhavaraju et al. · 2019 [cited by applicant]
US 20190339224A1 · Bhavaraju et al. · 2019 [cited by applicant]
US 20200008719A1 · Bremer · 2020 [cited by examiner]
JP 2009115519A · 2009 [cited by applicant]
JP 2014514093A · 2014 [cited by applicant]
JP 2014517281A · 2014 [cited by applicant]
JP 2017508158A · 2017 [cited by applicant]
KR 20180002231A · 2018 [cited by examiner]
WO WO2018204476A1 · 2018 [cited by applicant]
NPL Search Results, Apr. 30, 2021,1pp. (year: 2021). [cited by examiner]
Massart et al., [Eds.] [cited by applicant]
International Search Report and Written Opinion dated Dec. 2, 2019 for Application No. PCT/US2019/030450. [cited by applicant]
Office Action from European Patent Application No. 19796328.3, dated Dec. 10, 2020, 3 pages. [cited by applicant]
Kurasawa.S., et al., “Verification of Non-Invasive Blood Glucose Measurement Method Based on Pulse Wave Signal Detected by FBG Sensor System”, Sensors, Nov. 23, 2017, 13 pages. [cited by applicant]